GL1X · GenesisL1 explorer

MolNFT v1 · #89120 · protein

Oxime-based post solid-phase peptide diversification: identification of high affinity polo-like kinase 1 (PLK1) polo-box domain binding peptides

4DFW · SERINE/THREONINE-protein kinase PLK1: “Oxime-based post solid-phase peptide diversification: identification of high affinity polo-like kinase 1…”. X-ray diffraction, 3 ligands (ACE, CL, NH2), 2 pockets (best druggability 0.38).…

PDB
4DFW
Type
protein
Length
224 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
SERINE/THREONINE-protein kinase PLK1; Peptide
EC
2.7.11.21
UniProt
P53350
Ligands
ACE, CL, NH2
Pockets
2 · best druggability 0.38

Structure

x-ray diffraction · 2 distinct chains · 29% helix, 30% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
ASERINE/THREONINE-protein kinase PLK1 (EC 2.7.11.21)protein21930% helix, 30% strandP53350
DPeptideprotein50% helix, 40% strand—

Ligands and binding sites

  • ACE · Acetyl group · ligand · chains D
  • CL · Chloride ion · ion · 2 copies · chains A
  • NH2 · Amino group · ion · chains A, D

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

2 pockets found on a 1 Å grid, 0 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
1660.380.7919empty
2730.290.7315empty

Interfaces

1 interface between chains.

  • A–D · 627 Ų buried · 10 hydrogen bonds · protein-protein

Modifications

Observed in the structure: 2 modified, 1 covalent (covalent ligand, nonstandard, phosphorylation).

Compared structures

  • 4DFW · Oxime-based Post Solid-phase Peptide Diversification: Identification of High Affinity… · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.